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Highlights 
 REM sleep behavior disorder includes failure of muscle atonia but its visual assessment is 
demanding. 
 The proposed computer algorithm could quantify muscle activity comparable to human scorings and 
detected alterations in duration and amplitude of muscle activity. 
 The computer-based scoring might be a useful tools for quantification of altered muscle activity and 
detection of REM sleep behavior disorder. 
 
Abstract 
Background: Rapid eye movement (REM) sleep behavior disorder (RBD) is defined by dream enactment 
and a failure of muscle atonia. Visual assessment of this muscle activity is time consuming and rater-
dependent. Therefore, automated approaches are desired. 
Methods: A computer algorithm for scoring of ‘tonic’, ‘phasic’ and ‘any’ muscle activity was evaluated 
compared with ratings from human observers. Subsequently, 52 subjects were analyzed with the 
algorithm. Duration and maximal amplitude of muscle activity, and self-awareness of RBD symptoms were 
also assessed. 
Results: The computer algorithm showed high congruency with human ratings and all subjects with RBD 
were correctly identified by excess of ‘tonic’, ‘phasic’ and ‘any’ submental muscle activity, when artifacts 
were removed before analysis. Subjects with RBD exhibited prolonged ‘phasic’ muscle activity bouts with 
higher amplitude, and self-awareness of RBD symptoms correlated with amount of REM sleep without 
atonia. 
Discussion: Our proposed algorithm was able to detect and rate REM sleep without atonia, and allowed 
identification of RBD. Increased duration and amplitude of muscle activity bouts were additional 
characteristics of RBD. Quantification of REM sleep without atonia might represent a marker of RBD 
severity. 
Significance: Our computer algorithm can support diagnosis of RBD and quantification of altered muscle 
activity. 
 
Keywords: REM sleep without atonia, REM sleep behavior disorder, Parkinson’s disease 
3 
1. Introduction 
Rapid eye movement (REM) sleep behavior disorder (RBD) is a disorder defined by inappropriate muscle 
activity and enactment of dream content during REM sleep. RBD is closely connected to diseases with 
pathological aggregation of α-synuclein, including Parkinson’s disease (PD), dementia with Lewy bodies  
and multiple system atrophy (St Louis et al. , 2017). RBD often precedes overt motor symptoms of α-
synucleinopathies by years (Postuma et al. , 2015b, St Louis et al. , 2017), providing a window to study the 
early pre-motor and prodromal disease stages. Additionally, occurrence of RBD in established PD is related 
to more rapid and severe disease progression with a higher burden of non-motor symptoms (Neikrug et 
al. , 2014, Chahine et al. , 2016). Visual quantifications of REM sleep without atonia (RSWA) subclassify 
altered muscle activity into ‘tonic’ activity, representing sustained muscle activity and ‘phasic’ activity 
representing short lasting activity (Lapierre et al. , 1992, Frauscher et al. , 2012, McCarter et al. , 2014). 
Additionally, the term ‘any’ activity was introduced to account for overall muscle activity (Frauscher et al. 
, 2012). However, visual scorings are demanding and time consuming (Frauscher et al. , 2013); hence, 
computer-assisted quantification is a desirable tool.   
We developed a computer algorithm, which follows recently published rules for visual scoring of altered 
muscle activity proposed by McCarter and colleagues, which was reported to have high diagnostic accuracy 
even in the presence of sleep apnea (McCarter et al. , 2014). We integrated visual assessments of sleep 
stages, breathing events, arousals, and technical artifacts that are typically assessed during routine 
evaluation of a polysomnography (PSG), in this semi-automated algorithm. We aimed to assess 
comparability of scorings from the algorithm with two human raters and we subsequently tested the 
algorithm on 52 subjects. Additionally, we investigated if qualitative aspects of RSWA assessed with the 
algorithm - i.e. duration and amplitude of muscle activity - were different between subjects with and 
without RBD and if the amount of RSWA correlated to self-reported symptom awareness. 
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2. Methods 
2.1. Subjects 
We recruited 52 subjects, grouped into 23 subjects with RBD (RBD+), and 29 subjects without RBD (RBD-). 
The RBD- group included healthy subjects (healthy controls, HC; n = 15) and subjects with PD (PDRBD-; n = 
14); the RBD+ group included subjects with RBD but without signs of any other neurological disorder 
(‘idiopathic’ RBD, iRBD; n = 7), and subjects with PD (PDRBD+; n = 16). The clinical diagnosis of PD followed 
published consensus criteria from the Movement Disorder Society (MDS) (Postuma et al. , 2015a). Basic 
demographic characteristics were assessed as well as RBD symptoms with the RBD screening 
questionnaire (RBDSQ) (Stiasny-Kolster et al. , 2007). No subjects were receiving antidepressants or 
benzodiazepines; melatonin was stopped two weeks prior to sleep examination in one subject. Motor 
symptoms of PD patients were scored with the MDS Unified PD Rating Scale part III (MDS-UPDRS III) after 
12 hours of medication withdrawal. PD disease duration, dopaminergic medication and Hoehn and Yahr 
disease stage were also documented. Levodopa equivalent doses (LED) were calculated as proposed by 
Tomlinson et al (Tomlinson et al. , 2010). We did not record beginning of RBD as subjects reported to 
strong difficulties in reliable determination of the beginning of their RBD symptoms. All subjects were 
recruited by newspaper advertisements or from collaborating neurological clinics. The study was approved 
by the local ethical committee and all subjects gave written informed consent prior to inclusion. 
 
2.2. Polysomnography  
All subjects underwent overnight video-PSG with a SOMNOscreenTM plus Tele+Video (Somnomedics, 
Randersacker, Germany) device. Filter settings as well as scoring of sleep stages, arousals, respiratory 
events, and periodic leg movements followed standard recommendations and criteria (Berry et al. , 2017). 
Additionally, artifacts on the submental EMG were marked in the PSG software, i.e. transmission errors of 
the wireless PSG system or snoring artifacts with a typical waxing and waning pattern synchronous with 
airflow. RBD was diagnosed according to the criteria from the International Classification of Sleep 
Disorders version 3 (ICSD-3):  A. Repeated episodes of sleep related vocalization and/or complex motor 
behaviors; B. These behaviors are documented by polysomnography to occur during REM sleep or, based 
on clinical history of dream enactment, are presumed to occur during REM sleep; C. Polysomnographic 
recording demonstrates REM sleep without atonia; D. The disturbance is not explained more clearly by 
another sleep disorder, mental disorder, medication, or substance use. All criteria had to be fulfilled. If 
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subjects had increased apnea-hypopnea indices (AHI) >5/h, dream enacting behavior had to be present in 
the absence of any flow events or corresponding arousals.  
 
2.3. Visual scoring of REM sleep without atonia 
Using DOMINO software (SOMNOmedics, Randersacker, Germany), two neurologists (MS, MO), board-
certified in sleep medicine, visually scored RSWA in the first consecutive 10 PDRBD+ and 10 PDRBD- subjects 
according to previously proposed criteria by McCarter and colleagues (McCarter et al. , 2014). Raters were 
blinded to each other and to the results of the computer algorithm. RSWA scoring was performed on the 
submental muscle alone. Background EMG activity was set as a period of 30 - 60s of REM sleep without 
any visible muscle activity, and the root mean square (RMS) of the EMG signal during this time was 
computed; baseline values ranged from 1.01 - 3.46 μV (mean 1.45 ± 0.52). Details of scoring as described 
by McCarter and colleagues are given in the appendix. 
 
2.4. Algorithm for automatic computer detection of EMG activity 
EMG recordings (in European data format, EDF) and visual user markings of REM sleep epochs and artifacts 
(flow events, arousals, and artifacts) were extracted from the DOMINO software. They were further 
processed and analyzed in a custom-made computer program using LabVIEW 2016 (National Instruments). 
Scoring guidelines for RSWA were implemented as follows: To prepare computation of EMG samples of 
5ms precision, the EMG signal, recorded with a sampling rate of 256Hz, was resampled to 200Hz using 
spline interpolation. First, to detect ‘tonic’ activity, all 5ms samples with activity >2x baseline were marked 
as positive samples (= containing muscle activity) by a threshold detection. Second, if any artifact occurred 
during the 30s epoch, the whole epoch was excluded. Third, the time-array was divided into intervals of 
0.2s (40 samples) and a search algorithm marked each 0.2s period as a positive period, if any sample within 
the period was a positive sample. Finally, if a 30s REM epoch contained any continuous period >15s with 
positive samples (>75 x 0.2s positive samples), the REM epoch was marked as positive for ‘tonic’ activity.  
To detect ‘phasic’ activity, first the threshold for detection of the algorithm was set at >4x baseline activity, 
except during ‘tonic’ activity where the detection threshold was set to 2x RMS of the same ‘tonic’ activity 
period. This way, the phasic detection threshold changed for every registered ‘tonic’ activity, but only 
during the exact time period of the tonic activity. Second, all 5ms samples above the ‘phasic’ threshold 
were marked as positive samples and all marked artifacts were excluded in the same way as in the ‘tonic’ 
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activity detection. Third, a search algorithm was applied to find gaps of 0.1 - 0.2s (20 - 40 samples) between 
positive markings, and all samples were marked as positive samples if the gap was between 0.1 - 0.2s. The 
positive marking was eliminated in gaps > 0.2s or < 0.1s. In this way, all bursts less than 0.1s were 
discarded, and whenever there were more than 0.2s between two positive markings, the ‘phasic’ burst 
was considered to be terminated. Each 30s REM period was split into ten 3s mini-epochs, and if any artifact 
occurred during a mini-epoch, the entire mini-epoch was excluded from the analysis. A mini-epoch was 
regarded positive for ‘phasic’ activity if one or more ‘phasic’ bursts were registered at any time within the 
mini-epoch. If ‘phasic’ activity surpassed the limit between two mini-epochs, all mini-epochs containing 
activity were scored as epochs with ‘phasic’ activity. ‘Any’ activity was registered when either ‘phasic’ or 
‘tonic’ activity was present within a mini-epoch. Percentage of ‘phasic’ and ‘any’ activity was calculated by 
dividing the number of mini-epochs with activity by the total number of REM sleep mini-epochs and 
percentage of ‘tonic’ activity was calculated accordingly on 30s REM sleep epochs.  
Additionally, the duration as well as maximum amplitude of each ‘phasic’ burst were computed. Durations 
of all ‘phasic’ bursts were averaged for each subject for further analysis. Maximum amplitudes were 
normalized to individual’s background EMG and were averaged for each subject for further analysis.  
 
2.5. Statistical analysis 
We analyzed the data with the Statistical Package for the Social Sciences (SPSS) version 24. Group data are 
presented as mean ± standard deviation or as relative frequencies if not otherwise stated. Groups were 
compared using Student’s t-test, Mann-Whitney test, Kruskal-Wallis test and chi-square test as 
appropriate; non-parametric correlations were interrogated with Spearman’s rho. Normal distribution of 
data was assessed with the Shapiro-Wilk test, Q-Q plots, and box plots. Coefficient of determination (R²) 
and the Pitman-Morgan test were used to compare inter-rater variability on a subject level. Cohens Kappa 
was used to compare inter-rater variability on a single epoch level. Receiver operating curves (ROC) were 
calculated for ‘tonic’, ‘phasic’ and ‘any’ activity as well as for duration and amplitude of the ‘phasic’ bouts. 
Areas under the curve (AUC) were calculated for each analysis and cut-off thresholds are given for highest 
combined sensitivity and specificity, i.e. diagnostic accuracy.  
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3. Results 
3.1. Comparison of computer algorithm to visual scorings 
The computer algorithm was compared to observations of two human raters using the first consecutively 
recruited 10 PDRBD- and 10 PDRBD+ subjects. 3’175 30s epochs for ‘tonic’, and 33’576 3s epochs for ‘phasic’ 
and ‘any’ activity were considered after elimination of flow events, arousals, and artifacts (17% of 30s and 
12% of 3s epochs were discarded). Clinical characteristics did not differ between groups (Table 1). At a 
group level, elevated muscle activity in the PDRBD+ group was captured by both raters and the algorithm at 
high significance levels (all p<0.001, except p=0.005 for ‘tonic’ activity for rater 2), and there was good 
agreement between the two visual scorings and the computer algorithm; only ‘tonic’ activity in the PDRBD+ 
group was scored higher by rater 2 (Table 2). At an individual subject level, ratings for muscle activity 
showed a high correlation between both human raters (‘tonic’ activity, R²=0.936, ‘phasic’ activity, 
R²=0.877, ‘any’ activity, R²=0.982), and the algorithm exhibited high congruency to these ratings (‘tonic’ 
activity, R²=0.976 & R²=0.972; ‘phasic’ activity, R²=.979 & R²=0.846; ‘any’ activity, R²=0.989 & R²=0.982), 
see Figure 1. The Pitman-Morgan test revealed that the residuals of the regressions of each human rater 
with the computer algorithm were not greater than the residuals of the regressions of the human ratings 
for all three activities. Agreements of human and computer scorings on single epoch level were high for 
all activities (‘tonic’ activity both raters 97%, ‘phasic’ activity 95% & 93%, ‘any’ activity both raters 95%), 
comparable to the agreement between the human raters (94%, 87%, and 98%, respectively). Frequency-
corrected Cohen’s κ showed high agreement between human raters and the algorithm (‘tonic’ activity 
κ=0.74 & κ=0.78, ‘phasic’ activity κ=0.80 & κ=0.76, ‘any’ activity κ=0.83 & κ=0.82), which was similar to the 
κ values between the two human raters (‘tonic’ activity κ=0.64, ‘phasic’ activity κ=0.79, ‘any’ activity 
κ=0.82). 
 
3.2. Discrimination between RBD and non-RBD subjects by the computer algorithm  
Next, we interrogated all included subjects with the computer algorithm to test for group differences in 
amount of RSWA. Overall, 6’345 30s epochs, and 69’181 3s epochs were analyzed after elimination of flow 
events, arousals, and artifacts (19% of 30s and 12% of 3s epochs were discarded). Groups were comparable 
with regard to demographic and clinical characteristics (Table 3). RBD+ subjects exhibited highly significant 
increased ‘tonic’, ‘phasic’, and ‘any’ muscle activity compared to RBD- subjects (all p-values <0.001) (Table 
3). At an individual patient level, cut-off values with full differentiation between RBD+ and RBD- subjects 
were obtained for ‘phasic’ and ‘any’ activity (cut off values at >10% of REM sleep; range of RBD- subjects, 
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1.3 - 8.2% for ‘phasic’ and ‘any’; range of RBD+ subjects, 13.2 - 64.5% for ‘phasic’ and 13.3 - 77.4% for ‘any’, 
respectively). ‘Tonic’ activity gave an AUC of 0.976 at a cut-off value of 1.2% ‘tonic’ activity (range of RBD- 
subjects, 0 - 1.18%; range of RBD+ subjects, 0 - 66.3%, but only one iRBD subject had less than 1.2%) (Figure 
2). Of note, when using all epochs without removal of epochs containing flow events, arousals, and 
artifacts, precision of group separation was lower and cut-off values differed: AUC of ‘tonic’ activity = 0.940 
(cut-off = 2.2%), ‘phasic’ activity = 0.975 (cut-off = 15%), and ‘any’ activity = 0.978 (cut-off = 15%). 
 
3.3. Duration and amplitude of phasic EMG activity and RSWA related to reported symptom 
severity 
RBD+ subjects had longer duration of ‘phasic’ EMG bouts than RBD- subjects (p<0.001), and similarly, had 
higher amplitude of ‘phasic’ EMG bouts (p=0.008). ROC analysis resulted in an AUC of 0.909 for bout 
duration, and 0.768 for bout amplitude. A cut-off value of 405ms had a sensitivity of 91.3% and specificity 
of 82.8% to discriminate between RBD-negative and RBD-positive subjects. The amplitude value of 10.4 
times of baseline had a sensitivity of 78.3% and specificity of 69%, respectively. 
Subjects with higher scores on the RBDSQ exhibited a trend towards a higher amount of RSWA as shown 
in Figure 3; however, correlations were only significant when groups were pooled in the analysis (‘any’, 
rho=0.522, p<0.001; ‘phasic’, rho=0.515, p<0.001; ‘tonic’, rho=0.568, p<0.001). 
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4. Discussion 
We have presented a semi-automated computer algorithm for scoring and quantification of REM sleep 
without atonia, separated into ‘tonic’, ‘phasic’, and ‘any’ activity, which showed good agreement with 
human ratings on a group, subject, and single epoch level. Our computer algorithm displayed high 
diagnostic accuracy when detecting and separating subjects with RBD from subjects without RBD. RBD not 
only manifested as an excess of submental muscle activity during REM sleep, but also as prolonged muscle 
activity with increased amplitude. Self-awareness of RBD symptoms correlated with the amount of altered 
muscle activity. 
 
4.1. Considerations on the computer algorithm 
Our results are in line with growing positive experience on computerization of scoring of muscle activity 
during REM sleep. The ‘‘REM atonia index’’ (RAI) computer algorithm developed by Ferri and colleagues 
has found the most widespread application and showed good agreement with visual scoring of RSWA on 
individual subject level (Ferri et al. , 2008, Ferri et al. , 2014). However, the RAI algorithm uses different 
rules for scoring muscle activity than proposed visual rules and does not adhere to the general 30s epoch-
, and 3s mini-epoch-schemes, so a comparison with human ratings on an epoch level is difficult (Ferri et 
al. , 2008, Kempfner et al. , 2010, Frauscher et al. , 2013). Other computer algorithms also experienced 
good agreement with visual scorings on the subject level, but their validation mostly lacked comparison 
on a single epoch level or different measures of quantification of muscle activity were obtained with each 
method (Mayer et al. , 2008, Kempfner et al. , 2010, Frauscher et al. , 2014). In this study, we aimed to 
closely integrate visual scoring rules to a computer algorithm to obtain a high level of comparability 
between both methods. 
 
4.2. Classification of RBD, artifact management 
Our algorithm combined with visual artifact management correctly classified RBD subjects using a 
threshold of >1.2% ‘tonic’ activity and >10% ‘phasic’ or ‘any’ activity, irrespective of co-occurrence of PD 
or not. Its strong discriminating power with relatively low thresholds for altered muscle activity was a 
surprising finding, since accuracy is better than reported in previous studies using submental EMG alone 
(Lapierre et al. , 1992, Ferri et al. , 2008, Frauscher et al. , 2008, Ferri et al. , 2010, Kempfner et al. , 2010, 
Montplaisir et al. , 2010, Frauscher et al. , 2012, Frauscher et al. , 2013, McCarter et al. , 2014, Figorilli et 
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al. , 2017, McCarter et al. , 2017). We excluded REM sleep epochs that had a high likelihood of containing 
non-specific muscle activity, namely epochs containing apnea or hypopnea events and corresponding 
arousals (Iranzo et al. , 2005). We also visually assessed the submental EMG for artifacts during REM sleep; 
these were typically technical artifacts occurring because of brief transmission interruptions of the 
wireless PSG system as well as snoring artifacts with a typical waxing and waning pattern in the submental 
EMG synchronous to breathing or microphone measurements. Overall, 19% of 30s epochs and 12% of 3s 
epochs were excluded in our analysis; however, time consumption was low as assessment of breathing 
events and artifacts are part of a routine evaluation of a PSG. These numbers were higher than the ones 
reported by Figorilli et al. (Figorilli et al. , 2017), but could be one explanation for the high discriminative 
performance in our study. Without any artifact management, the discrimination power of our algorithm 
became slightly lower, but had similar AUC and cut-off values to those reported in its first description 
(McCarter et al. , 2014).  
 
4.3. Duration and amplitude of phasic muscle activity 
Our EMG analysis not only confirmed quantitatively increased muscle activity in RBD subjects, but also 
revealed increased duration and amplitude of ‘phasic’ EMG bouts. This is in line with the findings from 
McCarter and colleagues (McCarter et al. , 2014, McCarter et al. , 2017) as well as a previous report from 
Mayer et al (Mayer et al. , 2008). The etiology of RSWA genesis in humans is incompletely understood; 
based on animal models and scarce human studies, centers in the dorsal brainstem are suggested to play 
a key role in REM sleep initiation and maintenance (Lu et al. , 2006, Boeve et al. , 2007, Mayer et al. , 2015), 
and specifically the sublaterodorsal tegmental nucleus is supposed to be the key regulator of muscle atonia 
during REM sleep (Luppi et al. , 2011, Mayer et al. , 2015). Hence, malfunction of this complex in RBD might 
not only lead to a quantitative change of muscle atonia but also to a qualitative change of “leaked” muscle 
activity during REM sleep. Measures of duration and amplitude of ‘phasic’ activity might be useful for 
classification of borderline or unclear cases in a clinical setting. 
 
4.4. Amount of RSWA as a severity index 
We saw a tendency towards a higher degree of RSWA being linked to self-awareness of RBD symptoms as 
assessed with the RBDSQ. The RBDSQ was introduced as a screening questionnaire to identify subjects 
with RBD by asking for typical hallmarks of RBD expression (Stiasny-Kolster et al. , 2007). Even though it 
was not primarily designed to quantify the severity of RBD, one might argue that higher propensity to 
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dream enactment and classical RBD-like dream content might contribute to higher self-awareness and 
ultimately, represent a higher RBD severity. Additionally, a high level of RSWA was shown to predict the 
conversion of iRBD to PD in a longitudinal study (Postuma et al. , 2010), and was linked to more 
pronounced loss of dopaminergic terminals in a cross-sectional study (Eisensehr et al. , 2003). Additionally, 
a recent study reported a correlation between the amount of REM sleep atonia and the neuromelanin 
signal of the subcoeruleus/coeruleus complex in iRBD subjects and PD patients (Garcia-Lorenzo et al. , 
2013, Ehrminger et al. , 2016) .Hence, the amount of RSWA may help not only to identify RBD subjects, 
but might also represent a marker of RBD severity. Wider accessibility of fast and easy-to-use computer 
solutions for assessment of RSWA amount might facilitate future research in this field (Boeve et al. , 2016). 
 
4.5. Limitations of the study 
Several limitations of the study have to be noted. First, we only analyzed a limited number of 52 subjects; 
specifically, our iRBD sample was restricted. Secondly, subjects were all recorded with a single PSG monitor 
at a single center, potentially introducing a selection and analysis bias. However, overall number of 
analyzed subjects were in a similar range to previous reports (Frauscher et al. , 2008, Frauscher et al. , 
2012, McCarter et al. , 2014, Figorilli et al. , 2017, McCarter et al. , 2017), and we obtained similar values 
for ‘tonic’, ‘phasic’, and ‘any’ activity as reported in the initial report from McCarter and colleagues who 
used a different PSG monitor (McCarter et al. , 2014). We only included submental EMG recordings in our 
analysis, and inclusion of flexor digitorum superficialis, and extensor digitorum brevis muscles were 
reported to increase diagnostic accuracy for detection of RBD (Frauscher et al. , 2008). Even though, 
inclusion of these channels are preferable, they are not supported by all PSG monitors. On the other hand, 
assessment of qualitative changes of submental EMG activity, i.e. duration and amplitude of muscle bouts, 
and careful artifact management might overcome shortcomings from missing inclusion of additional 
muscles. 
 
4.6. Conclusions 
Our proposed semi-automated algorithm allows a fast quantitation of ‘tonic’, ‘phasic’, and ‘any’ activity 
with high agreement to visual ratings. Inclusion of a comprehensive visual artifact management may 
increase diagnostic accuracy by quantitative measures of altered muscle activity without significant time-
consumption. Prolonged muscle activity with increased amplitude is part of the altered atonia during REM 
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sleep in RBD. Finally, our results suggest that quantitative measures of RSWA reflect symptom severity, 
which could be advantageous for clinical trials. 
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A.1. Appendix 
Elevated muscle activity was scored as ‘tonic’, ‘phasic’, and ‘any’ activity as follows: ‘tonic’ activity was 
scored on 30s epochs and a 30s epoch was defined positive for ‘tonic’ activity if >50% of the epoch had 
continuous EMG activity greater than double the background activity. The return of muscle activity to 
baseline levels for at least 0.2s was considered as the end of the ‘tonic’ activity. Epochs with flow events 
(apnea or hypopnea), arousals, or artifacts were discarded from analysis. Percentage of ‘tonic’ activity was 
calculated by dividing the number of 30s epochs with ‘tonic’ activity by the total number of REM sleep 
epochs. To score ‘phasic’, and ‘any’ activity, each 30s epoch was subdivided into 10 3s mini-epochs for 
analysis. ‘Phasic’ activity was defined as EMG activity with amplitude >4x of the background activity and 
duration from 0.1 - 14.9s. The return of muscle activity to baseline levels for at least 0.2s was considered 
as end of a phasic burst. If ‘phasic’ activity surpassed the limit between two mini-epochs within a 30s 
epoch, all mini-epochs containing activity were scored as epochs with ‘phasic’ activity. During an epoch 
with ‘tonic’ activity, ‘phasic’ activity was scored, if EMG activity was >2x of the new baseline during the 
‘tonic’ activity (these epochs were counted as positive for ‘tonic’ and ‘phasic’) according to the proposed 
rules by McCarter and colleagues (McCarter et al. , 2014). Mini-epochs containing flow events, arousals, 
or artifacts were discarded from analysis. Percentage of ‘phasic’ activity was calculated by dividing the 
number of 3s mini-epochs with ‘phasic’ activity by the total number of 3s REM sleep mini-epochs. ‘Any’ 
activity was defined as 3s mini-epochs containing either ‘tonic’ or ‘phasic’ or both activities.  
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Tables and Figures 
 
Table 1: Demographic and clinical characteristics of validation cohort 
 PDRBD- PDRBD+ P-value 
Age 63.5 ± 9.2 66.4 ± 10.2 nsǂ 
Sex (male / female) 6 / 4 8 / 2 ns§ 
Disease duration [y] 5.0 ± 3.9 7.5 ± 4.3 ns¤ 
Hoehn & Yahr 2.0 ± 0.6 2.4 ± 0.6 ns¤ 
MDS-UPDRS III, total 30.9 ± 11.7 37.8 ± 12.2 nsǂ 
LED [mg] 576.3 ± 523.3 817.8 ± 307.0 nsǂ 
Sleep characteristics    
 RBDSQ 3.6 ± 2.3 6.7 ± 2.4 0.019¤ 
 Sleep efficiency [%] 86.6 ± 6.1 78.0 ± 12.8 ns¤ 
 Sleep latency [min] 16.8 ± 20.6 16.0 ± 11.4 ns¤ 
 Wake [%] 13.4 ± 6.0 22.0 ± 12.8 ns¤ 
 N1 [%] 12.4 ± 6.6 11.6 ± 6.1 nsǂ 
 N2 [%] 36.1 ± 8.6 38.9 ± 7.7 nsǂ 
 SWS [%] 15.8 ± 8.2 9.4 ± 3.1 nsǂ 
 REM [%] 22.2 ± 9.1 18.0 ± 10.6 ns¤ 
 AHI [h-1] 6.7 ± 6.5 8.2 ± 7.0 ns¤ 
ǂ = parametric test (Student’s t-test), ¤ = non-parametric test (Mann-Whitney test), § = χ² test. 
Abbreviations: AHI, apnea hypopnea index, LED, levodopa equivalent dose, N1, non-REM sleep 1, N2, non-
REM sleep 2, ns, not significant, RBD, rapid eye movement sleep behavior disorder, RBDSQ, RBD screening 
questionnaire, REM, rapid eye movement sleep, PD, Parkinson’s disease 
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Table 2: REM sleep atonia measures between raters and algorithm 
 PDRBD- P-Value PDRBD+ P-value 
RSWA indices algorithm rater1 rater2  algorithm rater1 rater2  
 Tonic [%] 0.1 ± 0.3 0.1 ± 0.3 1.3 ± 2.3 ns¤ 15.2 ± 18.4 13.2 ± 16.3 17.7 ± 20.9 0.030¤ * 
 Phasic [%] 3.9 ± 1.7 3.8 ± 1.8 4.2 ± 2.2 ns¤ 31.0 ± 13.8 30.9 ± 15.9 32.5 ± 16.7 ns¤ 
 Any [%] 3.9 ± 1.7 3.8 ± 1.8 3.2 ± 2.8 ns¤ 34.7 ± 17.9 34.2 ± 18.4 39.5 ± 20.4 ns¤ 
¤ = non-parametric test (Kruskal-Wallis test for all three groups, and Mann-Whitney test for two groups, respectively), *Pair-wise comparison: rater2 
against rater1, p=0.011, and rater2 against algorithm, p=0.043; rater1 against algorithm not significant. 
Abbreviations: ns, not significant, RBD, rapid eye movement sleep behavior disorder PD, Parkinson’s disease  
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Table 3: Demographic and clinical characteristics of groups analyzed with the algorithm 
 RBD- subjects RBD+ subjects P-value 
 all HC PDRBD- all PDRBD+ iRBD  
Age 66.2 ± 7.4 66.9 ± 5.8 65.4 ± 9.0 66.4 ± 8.2 66.7 ± 9.7 65.7 ± 3.9 nsǂ 
Sex (male / female) 20 / 9 10 / 5 10 / 4 18 / 5 12 / 4 6 / 1 ns§ 
Disease duration [y]   5.0 ± 3.6  8.0 ± 4.4  0.045¤ 
Hoehn & Yahr   2.1 ± 0.6  2.3 ± 0.5  ns¤ 
MDS-UPDRS III, total   32.6 ± 11.9  38.9 ± 10.5  nsǂ 
LED [mg]   547.0 ± 467.6  747.2 ± 329.6  nsǂ 
Sleep characteristics        
RBDSQ 3.0 ± 1.9 2.8 ± 1.7 3.3 ± 2.2 8.0 ± 3.2 7.3 ± 3.4 10.0 ± 1.7 <0.001¤ 
Sleep efficiency [%] 84.7 ± 6.7 83.5 ± 5.9 86.1 ± 5.9 84.3 ± 11.4 80.9 ± 12.01 92.1 ± 3.9 ns¤ 
Sleep latency [min] 14.8 ± 13.9 13.3 ± 7.9 16.4 ± 18.6 16.4 ± 11.3 15.0 ± 11.4 19.6 ± 11.2 ns¤ 
Wake [%] 15.2 ± 6.7 16.5 ± 7.4 13.9 ± 5.8 15.7 ± 11.4 19.1 ± 12.01 7.9 ± 3.9 ns¤ 
N1 [%] 15.3 ± 6.4 17.5 ± 5.4 13.0 ± 6.8 13.7 ± 6.6 12.6 ± 6.1 16.3 ± 7.5 nsǂ 
N2 [%] 38.3 ± 10.4 38.0 ± 11.3 38.7 ± 9.7 43.6 ± 9.5 41.7 ± 8.7 48.0 ± 10.3 nsǂ 
SWS [%] 14.1 ± 7.0 13.3 ± 5.9 14.9 ± 8.1 11.3 ± 4.2 10.3 ± 3.2 13.8 ± 5.8 nsǂ 
REM [%] 15.7 ± 8.2 12.6 ± 4.6 19.1 ± 9.9 15.5 ± 8.2 16.2 ± 9.3 13.9 ± 5.1 ns¤ 
AHI [h-1] 10.6 ± 8.5 12.7 ± 9.0 8.3 ± 7.5 9.4 ± 10.8 7.2 ± 6.2 15.3 ± 17.9 ns¤ 
RSWA indices        
Tonic [%] 0.1 ± 0.3 0.1 ± 0.3 0.1 ± 0.2 17.3 ± 19.8 19.4 ± 21.5 12.7 ± 15.8 <0.001¤ 
Phasic [%] 3.7 ± 2.0 3.2 ± 2.1 4.2 ± 1.8 34.2 ± 13.5 33.6 ± 12.6 35.6 ± 16.4 <0.001¤ 
Any [%] 3.7 ± 2.0 3.2 ± 2.1 4.2 ± 1.8 38.5 ± 17.7 38.5 ± 18.3 38.6 ± 17.8 <0.001¤ 
Duration [ms] 338.0 ± 77.8 328.8 ± 91.9 348.0 ± 49.1 487.7 ± 77.3 489.0 ± 82.3 484.7 ± 70.4 <0.001ǂ 
Max amplitude 10.2 ± 3.2 9.7 ± 3.5 10.8 ± 2.9 12.4 ± 2.4 12.4 ± 2.5 12.4 ± 2.2 0.008ǂ 
 
ǂ = parametric test (Student’s t-test), ¤ = non-parametric test (Mann-Whitney test), § = χ² test, 1 =  PDRBD+ 
and iRBD differed significantly 
Abbreviations: AHI, apnea hypopnea index, HC, healthy control subjects, iRBD, idiopathic RBD subjects, 
LED, levodopa equivalent dose, N1, non-REM sleep 1, N2, non-REM sleep 2, RBD, rapid eye movement 
sleep behavior disorder, RBDSQ, RBD screening questionnaire, REM, rapid eye movement sleep, PD, 
Parkinson’s disease 
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Figure 1: Validation of computer algorithm against raters on single subject level 
Figure A: Correlation plot of human raters assessing percentage of ‘tonic’, ‘phasic’, and ‘any’ muscle 
activity during REM sleep; line of unity in light grey. Figure B:  Correlation plot of computer algorithm 
scoring of percentage of ‘tonic’, ‘phasic’, and ‘any’ muscle activity during REM sleep against the two human 
raters from A; line of unity in light grey. 
 
Figure 2: Amount of increased muscle activity during REM sleep 
Dot-plots of single subjects’ percentage of increased ‘tonic’, ‘phasic’ and ‘any’ muscle activity during REM 
sleep. RBD+ subjects (PDRBD+ and iRBD) exhibited increased activity in all three qualities with cut-off values 
allowing best separation of groups of 1.2% for ‘tonic’ (line not shown), and 10% for ‘phasic’ and ‘any’ 
activity (light grey line), respectively. Note that only three RBD- subjects (one PDRBD- and two HC) had tonic 
activity, and only one RBD-positive subject had no ‘tonic’ activity. 
Abbreviations: HC, healthy control subjects, iRBD, idiopathic RBD subjects, RBD, rapid eye movement sleep 
behavior disorder, PD, Parkinson’s disease 
 
Figure 3: Correlation of RBDSQ and REM sleep without atonia 
Correlation plot of score on the rapid eye movement (REM) sleep behavior disorder screening 
questionnaire (RBDSQ) and percentage of increased ‘any’ activity during REM sleep. 
Abbreviations: HC, healthy control subjects, iRBD, idiopathic RBD subjects, RBD, rapid eye movement sleep 
behavior disorder, PD, Parkinson’s disease 
 
 
